• PDF: Delivered by email usually within 4 to 8 UK business hours.

Europe: Pharmaceuticals Industry Guide

  • Publication Date:March 2011
  • Publisher:Datamonitor
  • Product Type: Report
  • Pages:73

Europe: Pharmaceuticals Industry Guide

Datamonitor's Europe: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Europe Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
  • Provides textual analysis of the industry's prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

The European biotechnology market had total revenue of $50.6 billion in 2009, representing a compound annual growth rate (CAGR) of 9% for the period spanning 2005-2009.

The European generics market had total revenue of $34.1 billion in 2009, representing a compound annual growth rate (CAGR) of 10.1% for the period spanning 2005-2009.

The European OTC pharmaceuticals market generated total revenues of $39.9 billion in 2009, representing a compound annual growth rate (CAGR) of 3% for the period spanning 2005-2009.

The European pharmaceuticals market is forecast to have total revenue of $195.6 billion in 2010, representing a compound annual growth rate (CAGR) of 4.3% for the period spanning 2006-2010.

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research
  • BIOTECHNOLOGY IN EUROPE
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Five Forces Analysis
    • Market Forecasts
  • GENERICS IN EUROPE
    • Market Overview
    • Market Value
    • Market Volume
    • Market Segmentation II
    • Five Forces Analysis
    • Market Forecasts
  • OTC PHARMACEUTICALS IN EUROPE
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Market Share
    • Five Forces Analysis
    • Market Distribution
    • Market Forecasts
  • PHARMACEUTICALS IN EUROPE
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Market Share
    • Five Forces Analysis
    • Market Forecasts
  • APPENDIX
    • Data Research Methodology
    • About Datamonitor
    • Disclaimer
  • LIST OF TABLES
    • Table 1: Europe biotechnology market value: $ billion, 2005-09
    • Table 2: Europe biotechnology market segmentation I:% share, by value, 2009
    • Table 3: Europe biotechnology Market Segmentation II: % share, by value, 2009
    • Table 4: Europe biotechnology market value forecast: $ billion, 2009-14
    • Table 5: Europe generics market value: $ billion, 2005-09
    • Table 6: Europe generics market volume: volume penetration, 2005-09
    • Table 7: Europe generics Market Segmentation II: % share, by value, 2009
    • Table 8: Europe generics market value forecast: $ billion, 2009-14
    • Table 9: Europe generics market volume forecast: volume penetration, 2009-14
    • Table 10: Europe OTC pharmaceuticals market value: $ million, 2005-09
    • Table 11: Europe OTC pharmaceuticals market segmentation I:% share, by value, 2009
    • Table 12: Europe OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
    • Table 13: Europe OTC pharmaceuticals market share: % share, by value, 2009
    • Table 14: Europe OTC pharmaceuticals market distribution: % share, by value, 2009
    • Table 15: Europe OTC pharmaceuticals market value forecast: $ million, 2009-14
    • Table 16: Europe pharmaceuticals market value: $ billion, 2006-10(e)
    • Table 17: Europe pharmaceuticals market segmentation I:% share, by value, 2010(e)
    • Table 18: Europe pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
    • Table 19: Europe pharmaceuticals market share: % share, by value, 2010(e)
    • Table 20: Europe pharmaceuticals market value forecast: $ billion, 2010-15
  • LIST OF FIGURES
    • Figure 1: Europe biotechnology market value: $ billion, 2005-09
    • Figure 2: Europe biotechnology market segmentation I:% share, by value, 2009
    • Figure 3: Europe biotechnology Market Segmentation II: % share, by value, 2009
    • Figure 4: Forces driving competition in the biotechnology market in Europe, 2009
    • Figure 5: Drivers of buyer power in the biotechnology market in Europe, 2009
    • Figure 6: Drivers of supplier power in the biotechnology market in Europe, 2009
    • Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Europe, 2009
    • Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Europe, 2009
    • Figure 9: Drivers of degree of rivalry in the biotechnology market in Europe, 2009
    • Figure 10: Europe biotechnology market value forecast: $ billion, 2009-14
    • Figure 11: Europe generics market value: $ billion, 2005-09
    • Figure 12: Europe generics market volume: volume penetration, 2005-09
    • Figure 13: Europe generics Market Segmentation II: % share, by value, 2009
    • Figure 14: Forces driving competition in the generics market in Europe, 2009
    • Figure 15: Drivers of buyer power in the generics market in Europe, 2009
    • Figure 16: Drivers of supplier power in the generics market in Europe, 2009
    • Figure 17: Factors influencing the likelihood of new entrants in the generics market in Europe, 2009
    • Figure 18: Factors influencing the threat of substitutes in the generics market in Europe, 2009
    • Figure 19: Drivers of degree of rivalry in the generics market in Europe, 2009
    • Figure 20: Europe generics market value forecast: $ billion, 2009-14
    • Figure 21: Europe generics market volume forecast: volume penetration, 2009-14
    • Figure 22: Europe OTC pharmaceuticals market value: $ million, 2005-09
    • Figure 23: Europe OTC pharmaceuticals market segmentation I:% share, by value, 2009
    • Figure 24: Europe OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
    • Figure 25: Europe OTC pharmaceuticals market share: % share, by value, 2009
    • Figure 26: Forces driving competition in the OTC pharmaceuticals market in Europe, 2009
    • Figure 27: Drivers of buyer power in the OTC pharmaceuticals market in Europe, 2009
    • Figure 28: Drivers of supplier power in the OTC pharmaceuticals market in Europe, 2009
    • Figure 29: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Europe, 2009
    • Figure 30: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Europe, 2009
    • Figure 31: Drivers of degree of rivalry in the OTC pharmaceuticals market in Europe, 2009
    • Figure 32: Europe OTC pharmaceuticals market distribution: % share, by value, 2009
    • Figure 33: Europe OTC pharmaceuticals market value forecast: $ million, 2009-14
    • Figure 34: Europe pharmaceuticals market value: $ billion, 2006-10(e)
    • Figure 35: Europe pharmaceuticals market segmentation I:% share, by value, 2010(e)
    • Figure 36: Europe pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
    • Figure 37: Europe pharmaceuticals market share: % share, by value, 2010(e)
    • Figure 38: Forces driving competition in the pharmaceuticals market in Europe, 2010
    • Figure 39: Drivers of buyer power in the pharmaceuticals market in Europe, 2010
    • Figure 40: Drivers of supplier power in the pharmaceuticals market in Europe, 2010
    • Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2010
    • Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2010
    • Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2010
    • Figure 44: Europe pharmaceuticals market value forecast: $ billion, 2010-15
+44 20 8816 8548

Ask a question about Europe: Pharmaceuticals Industry Guide

Enter the characters you see in the picture below
Captcha